
Overview
Dr. Tolu is an Assistant Professor of Medicine in the Division of Hematology and Oncology, Center for Lymphoid Malignancies, at the Herbert Irving Comprehensive Cancer Center of Columbia University Irving Medical Center. Dr. Tolu earned her undergraduate degree in Neurobiology & Physiology at University of Maryland followed by her Medical Doctorate from University of Maryland, Baltimore. She completed her Internal Medicine residency at Montefiore Medical Center/Albert Einstein College Medicine where she had the honor of serving as Chief Resident. Dr. Tolu then went on to complete her fellowship in Hematology & Oncology at Columbia University Irving Medical Center, where she also served as Chief Fellow. Throughout her career, Dr. Tolu has earned several awards and scholarships for her research and academic achievements including the Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Research Scholarship, the Research Training Award for Fellows (RTAF), the Conquer Cancer Foundation Young Investigator Award (YIA), and the Cutaneous Lymphoma Foundation (CLF) YIA. She was also selected to participate in the prestigious American Association for Cancer Research (AACR)/Molecular Biology in Clinical Oncology Workshop, the American Society of Hematology (ASH)/Clinical Research Training Institute (CRTI), the Academy of Next Wave of Clinical Investigators in Non-Hodgkin’s Lymphoma, and the Food & Drug Administration (FDA)/American Society of Clinical Oncology (ASCO) Fellows Workshop. She continues to serve as a member of the Alpha Omega Alpha (AOA) Honor’s Society. Dr. Tolu’s pre-clinical research focuses on identifying synergistic targeted therapies using novel methods to accurately recapitulate lymphoma biology. As a clinical investigator, Dr. Tolu is highly involved in numerous clinical trials at Columbia spanning across Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Peripheral T-cell Lymphomas, and Cutaneous T-cell Lymphomas.
Dr. Tolu is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Sickle Cell Disease, Peripheral T-Cell Lymphoma, and Congenital Hemolytic Anemia.
She is actively involved in clinical research, co-authoring 34 peer reviewed articles. Dr. Tolu is currently accepting new patients.
Graduate Institution
Residency
Specialties
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Seda S. Tolu
How do I make an appointment with Dr. Seda S. Tolu?
You can book an appointment with Dr. Seda S. Tolu by calling their office at 212-305-5098. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Seda S. Tolu a top-rated expert for T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Seda S. Tolu is classified as an Advanced expert for T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Seda S. Tolu specialize in?
While Dr. Seda S. Tolu is a Hematology, they have specific expertise in T-Cell Lymphoma, Sickle Cell Disease, and Peripheral T-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Seda S. Tolu participate in research or clinical trials?
Yes. Dr. Seda S. Tolu has published 34 articles and abstracts on conditions like T-Cell Lymphoma. You can view a list of Dr. Seda S. Tolu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Seda S. Tolu accept my insurance?
Dr. Seda S. Tolu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-5098 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnemiaDr. Tolu isAdvanced. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Tolu isAdvanced. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Tolu isAdvanced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Tolu isAdvanced. Learn about Hemolytic Anemia.
- Non-Hodgkin LymphomaDr. Tolu isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Tolu isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Experienced
- B-Cell LymphomaDr. Tolu isExperienced. Learn about B-Cell Lymphoma.
- Colorectal CancerDr. Tolu isExperienced. Learn about Colorectal Cancer.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Tolu isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Hodgkin LymphomaDr. Tolu isExperienced. Learn about Hodgkin Lymphoma.
- Marginal Zone Lymphoma (MZL)Dr. Tolu isExperienced. Learn about Marginal Zone Lymphoma (MZL).